The outbreak of coronavirus disease 2019 (COVID-19) posed an unprecedented challenge
on public health systems. Despite the measures put in place to contain it, COVID-19 is likely …

Background Oseltamivir has been used as adjunctive therapy in the management of patients
with COVID-19. However, the evidence about using oseltamivir in critically ill patients with …

Background Oseltamivir is a low-cost antiviral agent that could support or complement
treatment of COVID-19. This study assessed whether oseltamivir is effective in reducing …

This study utilizes the enzyme-substrate complex theory to predict the clinical efficacy of
COVID-19 treatments at the biological systems level, using molecular docking stability …

The maneuver clinical investigation of an effective drug for coronavirus disease 2019
(COVID-19) is still ongoing and the milieu of a successful investigational drug with proven …

В период с января 2020 по май 2023 г. мировое сообщество столкнулось с пандемией
новой коронавирусной инфекции SARS-CoV-2. В связи с постоянной изменчивостью …

A fines de diciembre de 2019 se detectó una nueva neumonía de origen desconocido, en
pacientes que estaban vinculados a un mercado mayorista de mariscos y animales …

In the period from January 2020 to May 2023, the world community faced a pandemic of the
new coronavirus infection SARS CoV-2. Due to the constant variability of the virus and …